BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16584147)

  • 1. Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation.
    Patel VF; Patel NM
    AAPS PharmSciTech; 2006 Feb; 7(1):E17. PubMed ID: 16584147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation.
    Patel VF; Patel NM
    AAPS PharmSciTech; 2006 Mar; 7(1):E118-E124. PubMed ID: 28290032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of gastroretentive drug delivery system for cefuroxime axetil: in vitro and in vivo evaluation in human volunteers.
    Bomma R; Veerabrahma K
    Pharm Dev Technol; 2013; 18(5):1230-7. PubMed ID: 22348334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
    Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
    AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and characterization of cefuroxime axetil biphasic floating minitablets.
    Jammula S; Patra ChN; Swain S; Panigrahi KC; Nayak S; Dinda SC; Rao ME
    Drug Deliv; 2015 Jan; 22(1):125-35. PubMed ID: 24417642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of gastroretentive norfloxacin floating tablets.
    Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K
    Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and optimization of floating matrix tablets of clarithromycin using simplex lattice design.
    Singh I; Saini V
    Pak J Pharm Sci; 2016 Mar; 29(2):511-9. PubMed ID: 27087096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.
    Reddy AB; Reddy ND
    Drug Res (Stuttg); 2017 Jul; 67(7):412-418. PubMed ID: 28449156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.
    Patel A; Modasiya M; Shah D; Patel V
    AAPS PharmSciTech; 2009; 10(1):310-5. PubMed ID: 19296224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of cefuroxime axetil gastro-retentive floating drug delivery system via hot melt extrusion technology.
    Lalge R; Thipsay P; Shankar VK; Maurya A; Pimparade M; Bandari S; Zhang F; Murthy SN; Repka MA
    Int J Pharm; 2019 Jul; 566():520-531. PubMed ID: 31185262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of varying the restriction degree of 4-aminopyridine release from HPMC matrices on the mechanism controlling the process.
    Martínez-González I; Villafuerte-Robles L
    Int J Pharm; 2003 May; 257(1-2):253-64. PubMed ID: 12711180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-based intragastric delivery of cefuroxime axetil: development and in-vitro evaluation of mucoadhesive approach.
    Nagar M; Yadav AV
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Dec; 40(6):406-18. PubMed ID: 22780098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST; Patel LD; Patel DM
    Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
    Chen L; Wang F
    Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, development, and evaluation of floating pulsatile drug delivery system of atenolol.
    Jagdale SC; Sali MS; Barhate AL; Kuchekar BS; Chabukswar AR
    PDA J Pharm Sci Technol; 2013; 67(3):214-28. PubMed ID: 23752749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture.
    Ugurlu T; Turkoglu M; Gurer US; Akarsu BG
    Eur J Pharm Biopharm; 2007 Aug; 67(1):202-10. PubMed ID: 17337171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA; Lamas MC; Salamón CJ
    J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.